TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical-stage company pioneering immuno-oncology and RNA therapeutics for high-risk and advanced cancers, announced the retirement of Chief Financial Officer Tom Fitzgerald, effective immediately. Fitzgerald, who has served as CFO since July 2018 and also as a director, will continue to provide transition services to ensure a smooth handover.
The company has appointed John Tattory as interim CFO, effective immediately. Tattory brings more than 25 years of financial and operational management experience across the pharmaceutical, medical device, and biotechnology sectors. His career includes roles at Ernst & Young LLP, Bristol-Myers Squibb, Tyco International, Cerapedics, and Windtree Therapeutics. Currently, he serves as a managing director at Stout Risius Ross, where he provides consulting CFO services primarily to privately held life science companies.
The leadership change comes as TransCode Therapeutics advances its pipeline of innovative cancer treatments. The company’s lead therapeutic candidate, TTX-MC138, targets metastatic tumors that overexpress microRNA-10b, a well-documented biomarker of metastasis. TransCode also has a portfolio of other first-in-class candidates designed to mobilize the immune system to recognize and destroy cancer cells. The appointment of an interim CFO with Tattory’s depth of experience in life sciences finance is expected to support the company’s ongoing clinical development and financial strategy.
For investors, the transition at the CFO position is a key development to monitor, as financial leadership is critical for clinical-stage companies navigating the complexities of drug development and capital markets. TransCode Therapeutics remains focused on its mission to develop novel treatments for high-risk and advanced cancers. The full press release can be viewed at https://nnw.fm/8G3ik.
The latest news and updates relating to RNAZ are available in the company’s newsroom at https://nnw.fm/RNAZ. NetworkNewsWire, a specialized communications platform focused on financial news and content distribution, disseminated the announcement. For more information, visit https://www.NetworkNewsWire.com.
